Matches in Wikidata for { <http://www.wikidata.org/entity/Q65539198> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q65539198 description "clinical trial" @default.
- Q65539198 description "ensayu clínicu" @default.
- Q65539198 description "klinisch onderzoek" @default.
- Q65539198 description "клінічне випробування" @default.
- Q65539198 description "կլինիկական փորձարկում" @default.
- Q65539198 name "Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)" @default.
- Q65539198 name "Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization" @default.
- Q65539198 type Item @default.
- Q65539198 label "Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)" @default.
- Q65539198 label "Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization" @default.
- Q65539198 prefLabel "Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)" @default.
- Q65539198 prefLabel "Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization" @default.
- Q65539198 P1050 Q65539198-0EC1BA81-6CD5-40B2-A159-9E5CA89EB713 @default.
- Q65539198 P1132 Q65539198-33124A62-6A97-4CBC-BCBA-77ADB5A5EE7A @default.
- Q65539198 P1476 Q65539198-A3856005-EA3B-4161-B16F-7520D1A3D329 @default.
- Q65539198 P17 Q65539198-240C61BC-0F45-4534-B9CD-0457B3739BD8 @default.
- Q65539198 P1813 Q65539198-6816C5EA-75D4-449D-906B-A284FF6F3BD0 @default.
- Q65539198 P2899 Q65539198-FB1BA0AA-E8BB-42D9-99D0-D563644A9ABA @default.
- Q65539198 P3098 Q65539198-C9A3EAAA-3C52-4CCD-9041-FBD9ED223D24 @default.
- Q65539198 P31 Q65539198-CB22C373-168B-44F6-BC69-D4D959622639 @default.
- Q65539198 P4844 Q65539198-9BB1407A-BC03-4050-934D-89543B1685D7 @default.
- Q65539198 P580 Q65539198-DE2E7677-AEE7-4752-8515-D6B629CF07BE @default.
- Q65539198 P582 Q65539198-7F83C23D-E592-4A17-9590-8624B2F74DF9 @default.
- Q65539198 P6099 Q65539198-C7225FD9-768E-49FC-8AF0-5445D5E20D2B @default.
- Q65539198 P6153 Q65539198-D51B5BEB-1927-46FA-8731-D5786DBB118C @default.
- Q65539198 P8363 Q65539198-D567532F-48D1-46A6-BF1E-8C40E629F65A @default.
- Q65539198 P1050 Q27429789 @default.
- Q65539198 P1132 "+353" @default.
- Q65539198 P1476 "A Randomized, Double-masked, Active-controlled, Multi-center Study Comparing the Efficacy and Safety of Ranibizumab Administered as Two Dosing Regimens in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration" @default.
- Q65539198 P17 Q39 @default.
- Q65539198 P1813 "EXCITE" @default.
- Q65539198 P2899 "+50" @default.
- Q65539198 P3098 "NCT00275821" @default.
- Q65539198 P31 Q30612 @default.
- Q65539198 P4844 Q414270 @default.
- Q65539198 P580 "2005-12-01T00:00:00Z" @default.
- Q65539198 P582 "2008-01-01T00:00:00Z" @default.
- Q65539198 P6099 Q42824827 @default.
- Q65539198 P6153 Q507154 @default.
- Q65539198 P8363 Q78089383 @default.